We are live on ! Find out more
CA

Cortland Associates Portfolio holdings

AUM $692M
1-Year Est. Return 5%
This Fund
S&P 500
This Quarter Est. Return
+10.87%
1 Year Est. Return
-5%
3 Year Est. Return
+57.07%
5 Year Est. Return
+61.48%
10 Year Est. Return
+413.35%
AUM
$488M
AUM Growth
+$68.1M
Cap. Flow
+$21.3M
Cap. Flow %
4.37%
Top 10 Hldgs %
79.19%
Holding
45
New
4
Increased
10
Reduced
14
Closed
5

Top Buys

Rank Stock Value
1
HRI icon
Herc Holdings
HRI
+$19.5M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$9.34M
3
BABA icon
Alibaba
BABA
+$518K
4
PG icon
Procter & Gamble
PG
+$287K
5
CELG
Celgene Corp
CELG
+$200K

Top Sells

Rank Stock Value
1
CLB icon
Core Laboratories
CLB
+$5.88M
2
PX
Praxair Inc
PX
+$873K
3
FAST icon
Fastenal
FAST
+$565K
4
QCOM icon
Qualcomm
QCOM
+$515K
5
EMR icon
Emerson Electric
EMR
+$201K

Sector Composition

Rank Sector Weight
1 Healthcare 27.79%
2 Financials 19.68%
3 Technology 16.29%
4 Communication Services 11.86%
5 Materials 9.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XOM icon
26
ExxonMobil
XOM
$638B
$347K 0.07%
3,756
+720
+24% +$67.1K
SHW icon
27
Sherwin-Williams
SHW
$87.8B
$342K 0.07%
3,900
– –
PG icon
28
Procter & Gamble
PG
$345B
$297K 0.06%
+3,262
New +$287K
MO icon
29
Altria Group
MO
$114B
$278K 0.06%
5,637
+16
+0.3% +$779
MSFT icon
30
Microsoft
MSFT
$3.66T
$223K 0.05%
4,810
– –
ECYT
31
DELISTED
Endocyte, Inc. Common Stock
ECYT
$220K 0.05%
35,000
-31,000
-47% -$189K
CELG
32
DELISTED
Celgene Corp
CELG
$213K 0.04%
+1,900
New +$200K
EFG icon
33
iShares MSCI EAFE Growth ETF
EFG
$17B
$207K 0.04%
3,150
– –
CALD
34
DELISTED
Callidus Software, Inc.
CALD
$196K 0.04%
12,000
– –
AHPI
35
DELISTED
Allied Healthcare Products
AHPI
$18K ﹤0.01%
5,000
– –
ACUR
36
DELISTED
Acura Pharmaceuticals
ACUR
$10K ﹤0.01%
4,310
-3,500
-45% -$9.68K
CLB icon
37
Core Laboratories
CLB
$515M
– –
-40,162
Closed -$5.88M
EMR icon
38
Emerson Electric
EMR
$89B
– –
-3,204
Closed -$201K
SIRI icon
39
SiriusXM
SIRI
$10.4B
– –
-2,000
Closed -$70K
VIVS
40
VivoSim Labs
VIVS
$1.28M
– –
-42
Closed -$64K
TSCC
41
DELISTED
TECHNOLOGY SOLUTIONS CO NEW
TSCC
$0 ﹤0.01%
12,625
– –
HK
42
DELISTED
Halcon Resources Corporation
HK
– –
-232
Closed -$158K
1
2

Similar funds

CL
CIM LLC Albany, New York $692M AUM 22.9% 1-Year Est. Return
CPA
Capital Planning Advisors Roseville, California $692M AUM 21.81% 1-Year Est. Return
NMC
Nine Masts Capital Central, Hong Kong $693M AUM 31.93% 1-Year Est. Return
SSA
South Street Advisors New York $690M AUM 39.17% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
CGIC
Continental General Insurance Company Austin, Texas $693M AUM 90.58% 1-Year Est. Return
LCP
Larch Capital Partners Miami, Florida $690M AUM
SAM
Southernsun Asset Management Memphis, Tennessee $690M AUM 30.68% 1-Year Est. Return

Cortland Associates's Q4 2014 Portfolio in Review

As of Q4 2014, Cortland Associates held 45 positions worth $488M, up 16% from $420M the previous quarter. Its ten largest holdings account for 79% of the portfolio.

Cortland Associates deployed $21.3M of net new capital in Q4 2014, opening 4 new positions and adding to 10 existing holdings. Its largest new stake was Herc Holdings: 288,958 shares worth $21.6M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 27% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Praxair Inc, an estimated $873K trimmed.

  • Cortland Associates's largest Q4 2014 buy was Herc Holdings: 288,958 shares worth $21.6M.
  • Cortland Associates added most to Alphabet (Google) Class C in Q4 2014, an estimated $9.34M increase.
  • Cortland Associates's biggest Q4 2014 reduction was Praxair Inc, cutting an estimated $873K.
  • Cortland Associates fully exited Core Laboratories in Q4 2014, selling an estimated $5.88M.
  • Cortland Associates's ten largest holdings make up 79% of its $488M portfolio in Q4 2014.
  • Cortland Associates opened 4 new positions and closed 5 in Q4 2014.
  • Cortland Associates's portfolio value rose 16% quarter-over-quarter to $488M.

Based on Cortland Associates's 13F filing for Q4 2014, filed 13 Feb 2015.